CXCL14 drives age-related intervertebral disc degeneration via NF-κB pathway activation in a multiomic study.

Researchers have discovered a key biological marker that may explain why intervertebral discs deteriorate with age, causing chronic low back pain. Scientists compared tissue samples from three elderly patients with degenerative disc disease to three younger patients with disc injuries, using advanced genetic and protein analysis techniques. They found that a specific protein called CXCL14 was significantly elevated in older patients—more than four times higher than in younger patients. This protein appears to trigger inflammation and breakdown of the cushioning material between vertebrae by activating a cellular pathway called NF-κB, which promotes tissue degradation. The researchers confirmed their findings using additional genetic databases and laboratory testing, consistently showing CXCL14 overexpression in age-related disc degeneration. For patients considering acupuncture, this research is relevant because it confirms that age-related disc degeneration involves specific inflammatory processes. Traditional acupuncture has been shown in other studies to modulate inflammatory pathways and may help address pain associated with these degenerative changes. While this study focuses on identifying drug targets rather than acupuncture specifically, understanding the inflammatory nature of disc degeneration supports the rationale for anti-inflammatory approaches like acupuncture. The findings suggest that treatments addressing inflammation and the NF-κB pathway may be particularly beneficial for older adults with chronic low back pain from disc problems. If you're experiencing chronic low back pain from disc degeneration, consult with a licensed acupuncturist who can develop an individualized treatment plan addressing your specific condition.

This multiomics study integrated transcriptomic and proteomic analyses of tissue samples from three elderly IDD patients versus three younger patients with disc lesions. Using RNA sequencing and mass spectrometry, researchers identified 45 differentially expressed genes and 34 differentially expressed proteins. CXCL14 emerged as the sole molecule significantly upregulated at both transcriptome (4.2-fold, p<0.001) and proteome levels (3.8-fold, p=0.003) in age-related IDD. RT-qPCR validation confirmed CXCL14 overexpression (log2-fold change=4.1, p<0.001), corroborated by external dataset analysis. Gene regulatory network analysis revealed CXCL14 interactions with IL-1β and TNF-α, activating the NF-κB pathway—a primary driver of extracellular matrix degradation and inflammation. ceRNA network analysis identified hsa-miR-582-3p and hsa-miR-150-5p as potential upstream regulators. Clinical relevance: CXCL14-mediated NF-κB activation represents a targetable inflammatory mechanism in age-related IDD, supporting therapeutic approaches that modulate inflammatory cascades, including acupuncture's documented anti-inflammatory effects on chronic low back pain.